Coronary artery disease in postmenopausal women

Author:

Mora Samia,Kershner Dawn Warner,Vigilance Camille Peart,Blumenthal Roger S.

Publisher

Springer Science and Business Media LLC

Subject

Cardiology and Cardiovascular Medicine

Reference66 articles.

1. Gibbons RJ, Chatterjee K, Daley J, et al.: ACC/AHA/ACPASIM guidelines for the management of patients with chronic stable angina: executive summary and recommendations: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on Management of Patients with Chronic Stable Angina). Circulation 1999, 99:2829–2848. Recommends the main treatment categories for possible consideration in all patients with coronary heart disease, which are antiplatelet agents, beta-blockers, blood-pressure control, cholesterol management, avoidance of tobacco products, diabetes control, dietary improvements, and exercise.

2. Hulley S, Grady D, Bush T, et al., for the Heart and Estrogen/progestin Replacement Study (HERS) Research Group: Randomized trial of estrogen plus progestin for secondary prevention of coronary heart disease in postmenopausal women. JAMA 1998, 280:605–613. The first large randomized, double-blind, placebo-controlled trial of the effects of HRT on CAD risk: after 4 years of followup, HRT did not reduce CAD events in postmenopausal women with CAD, with an observed early increase in CAD events with HRT.

3. American Heart Association: 2000 Heart and Stroke Facts: Statistical Update. Dallas: American Heart Association; 1999.

4. Mosca L, Jones WK, King KB, et al., for the American Heart Association Women’s Heart Disease and Stroke Campaign Task Force: Awareness, perception, and knowledge of heart disese risk and prevention among women in the United States. Arch Fam Med 2000, 9:506–515.

5. Centers for Disease Control and Prevention: Missed opportunities in preventive counseling for cardiovascular disease—United States, 1995. MMWR Morb Mortal Wkly Rep 1998, 47:91–95.

Cited by 7 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3